Microbial Risk and Investigations (single user digital version)

Table of Contents:

Click here to download >>>Detailed Table of Contents

1. Introduction by Karen Zink McCullough and Jeanne Moldenhauer
2. Conducting Microbial Deviations and Investigations by Frank Settineri
3. Preparing for and Conducting Successful Investigations by Scott Sutton
4. The Microbiologists's Tool Box by Hilary Chan, Lynn Johnson, and Jill Larivee
5. Quality Metrics by Karen Zink McCullough
6. Antimicrobial Efficacy Testing in Risk Assessment by Phil Geis
7. Objectionable Organisms in Non-Sterile Pharmaceutical Drug Products: Risk Assessment and Origins of Contamination by David Roesti
8. Microbiological Out-of-Specification and Out-of-Trend Investigations in Non-Sterile Pharmaceutical Manufacturing — A Contract Laboratory Perspective by Rick Jakober
9. Investigating Sterility Test Failures by Tim Sandle
10. Conducting Sterility Test Investigations Using the FDA Model by Jeanne Moldenhauer
11. Determining the Product Risk when Contamination Occurs in Environmental Monitoring by Jeanne Moldenhauer
12. Levering Risk Assessments in Environmental Monitoring Investigations by Karen Ginsbury
13. Microbial Investigation Case Studies by Ken Muhvich
14. Assessment of Environmental Monitoring Data in Support of Aseptic Manufacturing by Veronica Marshall, David Correal, Mulyadi Setiawan and Karen Zink McCullough
15. Investigations for Personnel Monitoring by Anne Marie Dixon
16. Real-Time Risk Assessment Control Strategy by Sean Toler
17. Mold Contamination by Brian G. Hubka and Jeanne Moldenhauer
18. Microbial Excursions in Cleanrooms by Jim Polarine and Carol Bartnett
19. Failure Investigations in Response to Adverse Aseptic Filling Simulation Results by Tony Cundell
20. Investigation of Endotoxin Out-of-Specification and Unexpected Results by James F. Cooper
21. Investigation of Microbiological Excursions During a Water System Validation by Karen Zink McCullough
22. Particulate Matter in Injectable Drug Products by Stephen E. Langille
23. Investigating Microbial Identification Results by Jeanne Moldenhauer
24. Addressing Deviations in Biological Indicator Population Counts and D-Value Analysis by Jeanne Moldenhauer and I.J. Pflug
25. Investigating Positive Biological Indicators or Insufficient Kill of Indicators in Sterilization Studies by Jeanne Moldenhauer
26. Conducting Investigations Rapid Microbiology Methods by Jeanne Moldenhauer
27. Contamination Risks and the Patient by Mark Hunter, Michelle Luebke, and Mark Pasmore
28. Contamination Control Risk Assessment by Tim Sandle

About the Editors

Jeanne Moldenhauer, Excellent Pharma Consulting, has nearly 30 years of experience in the pharmaceutical industry. She chairs the PDA Environmental Monitoring/Microbiology Interest Group, serves on the PDA Scientific Advisory Board, founded the Rapid Microbiology User`s Group TM, and is a member of ASQ and RAPS. She is the author of Recent Warning Letters Review for Preparation of a Non-Sterile Processing Inspection, Volume 2; Recent Warning Letters Review for Preparation of an Aseptic Processing Inspection and the Editor of Steam Sterilization: A Practitioner`s Guide; Laboratory Validation: A Practitioner`s Guide; Systems Based Inspections for Pharmaceutical Manufacturers and Thermal Validation in Moist Heat Sterilization among numerous other recent publications. She is the winner of the 2010 and 2005 PDA/DHI Distinguished Editor/Author Award.

Karen Zink McCullough, is principal consultant at MMI Associates, a consulting firm specializing in Endotoxin and Microbiology testing compliance. Ms. McCullough has over 35 years of experience in the Bacterial Endotoxins Test, and was the first to publish on the use of the LAL test for release of small volume parenterals. She teaches globally on Endotoxin and microbiological testing. Her current interest is the use of the BET assay as a tool for process control. She is a charter member and current Chair of the LAL Users' Group, a member of the United States delegation to TC209, WG02, ISO 14698 (Biocontamination) standard revision, and also a member of the Microbiology General Chapters Expert Committee of the United States Pharmacopeia.